Affiliation: Nanjing University

Dr. Christopher Butch received his PhD in chemical engineering from the Georgia Institute of Technology in 2014. He then worked as a postdoctoral researcher in computational medicinal chemistry at Emory University in the laboratory of Dennis Liotta where he contributed to the development of CXCR-4 antagonists, NMDA receptor potentiators, and antiviral compounds for use against HIV and HCV. He joined the department of Biomedical Engineering at Nanjing University as an Associate Professor in 2019. At NJU his work focuses on using computational methods to design high performance nanoparticles for biomedical applications including small molecule delivery, imaging applications, and nano-scale therapeutic agents